Impact of changing PSVR thresholds on the patency rates of SFA recanalisation with self-expanding nitinol stents

EuroIntervention

Volumn 9, Issue 8, 2013, Pages 964-967

  Higashimori, Akihiro ^a   Kawarada, Osami ^b   Morioka, Nobuyuki ^a   Shiotani, Shinji ^a   Fujihara, Masahiko ^a   Fukuda, Keisuke ^a   Yokoi, Yoshiaki ^a  

^a Kishiwada Tokushukai Hospital   (Japan)

^b NATIONAL CEREBRAL AND CARDIOVASCULAR CENTER   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

NITINOL;

AGED; ARTERY DISEASE; ARTICLE; CARDIOVASCULAR PARAMETERS; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PEAK SYSTOLIC VELOCITY RATIO; RECANALIZATION; RESTENOSIS; RETROSPECTIVE STUDY; SELF EXPANDING STENT; SUPERFICIAL FEMORAL ARTERY; SUPERFICIAL FEMORAL ARTERY DISEASE; SUPERFICIAL FEMORAL ARTERY RECANALIZATION; TREATMENT RESPONSE; VASCULAR PATENCY;

AGED; AGED, 80 AND OVER; ALLOYS; CONSTRICTION, PATHOLOGIC; FEMALE; FEMORAL ARTERY; FOLLOW-UP STUDIES; HUMANS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; STENTS; VASCULAR PATENCY;

EID: 84892916292     PISSN: 1774024X     EISSN: 19696213     Source Type: Journal    
DOI: 10.4244/EIJV9I8A161     Document Type: Article

References (11)

1. Dake MD, Scheinert D, Tepe G, Tessarek J, Fanelli F, Bosiers M, Ruhlmann C, Kavteladze Z, Lottes AE, Ragheb AO, Zeller T; Zilver PTX Single-Arm Study Investigators. Nitinol stents with polymer-free paclitaxel coating for lesions in the superficial femoral and popliteal arteries above the knee: twelve-month safety and effectiveness results from the Zilver PTX single-arm clinical study. J Endovasc Ther. 2011;18:613-23.
2. Bosiers M, Torsello G, Gissler HM, Ruef J, Müller-Hülsbeck S, Jahnke T, Peeters P, Daenens K, Lammer J, Schroë H, Mathias K, Koppensteiner R, Vermassen F, Scheinert D. Nitinol stent implantation in long superficial femoral artery lesions: 12-month results of the DURABILITY I study. J Endovasc Ther. 2009;16:261-9.
3. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007;45 Suppl S:S5-67.
4. Suzuki K, Iida O, Soga Y, Hirano K, Inoue N, Uematsu M, Yokoi H, Muramatsu T, Nanto S, Nobuyoshi M, Meguro T. Long-term results of the S.M.A.R.T. Control(TM) stent for superficial femoral artery lesions, J-SMART registry. Circ J. 2011;75:939-44.
5. Kawarada O, Higashimori A, Noguchi M, Waratani N, Yoshida M, Fujihara M, Yokoi Y, Honda Y, Fitzgerald PJ. Duplex criteria for in-stent restenosis in the superficial femoral artery. Catheter Cardiovasc Interv. 2013;81:E199-E205.
6. Norgren L, Hiatt WR, Dormandy JA, Nehler MR, Harris KA, Fowkes FG; TASC II Working Group. Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II). J Vasc Surg. 2007 Jan;45 Suppl S:S5-67.
7. Anderson PL, Gelijns A, Moskowitz A, Arons R, Gupta L, Weinberg A, Faries PL, Nowygrod R, Kent KC. Understanding trends in inpatient surgical volume: vascular interventions, 1980- 2000. J Vasc Surg. 2004;39:1200-8.
8. Goodney PP, Beck AW, Nagle J, Welch HG, Zwolak RM. National trends in lower extremity bypass surgery, endovascular interventions, and major amputations. J Vasc Surg. 2009;50:54-60.
9. Rowe VL, Lee W, Weaver FA, Etzioni D. Patterns of treatment for peripheral arterial disease in the United States: 1996-2005. J Vasc Surg. 2009;49:910-7.
10. Sabeti S, Schillinger M, Amighi J, Sherif C, Mlekusch W, Ahmadi R, Minar E. Primary patency of femoropopliteal arteries treated with nitinol versus stainless steel self-expanding stents: pro-pensity score-adjusted analysis. Radiology. 2004;232:516-21.
11. Nakamura M. The door is open and the next step is forthcoming-lesson from J-SMART registry. Circ J. 2011;75:786-8.